SCHEMBL3826045

SCHEMBL3826045

Cn1c(NCCO)nc2c(NCc3ccccc3)ncnc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 6/20 0.56
TMIGD3 P0DMS9 4/20 0.55
ADORA2A P29274 4/20 0.55
ADORA1 P30542 4/20 0.55
ADORA2B P29275 3/20 0.55
PKM P14618 1/20 0.54
CDK2 P24941 4/20 0.54
CCNB2 O95067 3/20 0.54
CCNB1 P14635 3/20 0.54
CCNB3 Q8WWL7 3/20 0.54
CDK5 Q00535 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
KDM4E B2RXH2 1/20 0.54
CCNE2 O96020 1/20 0.54
ALDH1A1 P00352 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
GAA P10253 1/20 0.54
CYP2D6 P10635 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7008070 0.86 CDK1 (0.57) CDK1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL6919436 0.76 CDK1 (0.58) CDK1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL7008061 0.74 CDK1 (0.59) CDK1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL28068467 0.73 TMIGD3 (0.77) CDK1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL28823370 0.73 CDK1 (0.57) CDK1CDK2CCNB2CCNB1CCNB3
SCHEMBL8677222 0.73 CDK1 (0.57) CDK1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL7099130 0.73 CDK1 (0.69) CDK1CDK2CCNB2CCNB1CCNB3
SCHEMBL2098867 0.73 CDK1 (0.63) CDK1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL4382069 0.72 CDK1 (1.00) CDK1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL7006036 0.71 ADORA2A (0.66) CDK1TMIGD3ADORA2AADORA1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104603113-B Novel 2, 3-dihydro-1H-imidazo {1,2-a } pyrimidin-5-one and 1,2,3, 4-tetrahydropyrimidino {1,2-a } pyrimidin-6-one derivatives comprising substituted morpholines, preparation thereof and pharmaceutical use thereof 赛诺菲 2020-01-21 CN disclosed
EP-2094699-A2 NEW IMIDAZOLONE DERIVATIVES, PREPARATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF AS PROTEIN KINASE INHIBITORS, IN PARTICULAR CDC7 Sanofi-Aventis (FR) 2009-09-02 EP disclosed
WO-2008046982-A2 NEW IMIDAZOLONE DERIVATIVES, PREPARATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF AS PROTEIN KINASE INHIBITORS, IN PARTICULAR CDC7 SANOFI-AVENTIS (FR) 2008-04-24 WO disclosed
EP-1261603-B1 FLAVONE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA SA (FR) 2006-08-16 EP disclosed
EP-1633738-A2 NOVEL INDOLE DERIVATIVES, METHOD OF PREPARING SAME IN THE FORM OF MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND, IN PARTICULAR, KDR INHIBITORS Aventis Pharma S.A. (FR) 2006-03-15 EP disclosed
EP-1532134-A1 NOVEL THIOPHENE ACYL HYDRAZINO DERIVATIVES, METHOD FOR PREPARING SAME, USE THEREOF AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE Aventis Pharma S.A. (FR) 2005-05-25 EP disclosed
WO-2004096792-A2 NOVEL INDOLE DERIVATIVES, METHOD OF PREPARING SAME IN THE FORM OF MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND, IN PARTICULAR, KDR INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-11-11 WO disclosed
WO-2004007477-A1 NOVEL THIOPHENE ACYL HYDRAZINO DERIVATIVES, METHOD FOR PREPARING SAME, USE THEREOF AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE AVENTIS PHARMA S.A. (FR) 2004-01-22 WO disclosed
EP-1261603-A1 FLAVONE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2002-12-04 EP disclosed
WO-2001064673-A1 FLAVONE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2001-09-07 WO disclosed